Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
How can controlled human infection models accelerate clinical development and policy pathways for vaccines against
Birgitte K Giersing1, Chad K Porter2, Karen Kotloff3
1Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, World Health Organization Headquarters, 20 Avenue Appia, 1211-CH 27 Geneva, Switzerland.
Abstract:
Controlled Human Infection Models (CHIMs) now exist for several infectious diseases. CHIMs offer significant insight into disease pathogenesis, as well the potential to rapidly test clinical proof-of-concept of vaccine candidates. The application of CHIMs to identify a correlate of protection that may reduce the sample size of, or obviate the need for clinical efficacy studies to achieve licensure is of considerable interest to vaccine developers and public health stakeholders. This topic was the subject of a workshop at the 2018 Vaccines Against Shigella and ETEC (VASE) conference, in the context of O-antigen-based Shigella vaccines.
Insights
Controlled Human Infection Models (CHIMs) provide valuable insights into disease pathogenesis and vaccine development. CHIMs show promise for identifying correlates of protection, potentially streamlining vaccine licensure and efficacy studies.
Area of Science:
- Infectious diseases
- Vaccinology
- Immunology
Background:
- Controlled Human Infection Models (CHIMs) are established for various infectious diseases.
- CHIMs offer deep insights into disease pathogenesis.
- They enable rapid clinical proof-of-concept testing for vaccine candidates.
Purpose of the Study:
- To explore the utility of CHIMs in identifying correlates of protection.
- To discuss how correlates of protection can reduce sample sizes for clinical efficacy studies.
- To examine the application of CHIMs in the context of Shigella vaccine development.
Main Methods:
- Workshop discussion at the 2018 Vaccines Against Shigella and ETEC (VASE) conference.
- Focus on O-antigen-based Shigella vaccines.
- Review of existing CHIM applications and potential for correlate identification.
Main Results:
- CHIMs are a valuable tool for understanding pathogenesis.
- Identifying correlates of protection via CHIMs is of significant interest.
- CHIMs can potentially reduce the need for large-scale efficacy trials.
Conclusions:
- CHIMs are crucial for advancing vaccine development and understanding disease.
- Correlates of protection identified through CHIMs can accelerate vaccine licensure.
- Further research into CHIMs for Shigella vaccines is warranted.
Related Concept Videos
Vaccinations
Endocarditis II: Clinical Features of Infective Endocarditis
Accelerators
The effectiveness of calcium chloride can...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Accelerating Fluids
The motion of the liquid within this infinitesimal cylinder is considered to obtain the pressure difference. Three vertical forces act on this liquid:
Instantaneous Acceleration

